loading
전일 마감가:
$2.04
열려 있는:
$2.07
하루 거래량:
11.20M
Relative Volume:
0.88
시가총액:
$794.76M
수익:
$32.77M
순이익/손실:
$-440.22M
주가수익비율:
-1.1856
EPS:
-1.67
순현금흐름:
$-400.48M
1주 성능:
-11.61%
1개월 성능:
+3.66%
6개월 성능:
-73.17%
1년 성능:
-75.16%
1일 변동 폭
Value
$1.97
$2.088
1주일 범위
Value
$1.95
$2.22
52주 변동 폭
Value
$1.6385
$12.51

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Name
명칭
Iovance Biotherapeutics Inc
Name
전화
(650) 260-7120
Name
주소
825 INDUSTRIAL ROAD, SAN CARLOS
Name
직원
838
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
IOVA's Discussions on Twitter

IOVA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IOVA
Iovance Biotherapeutics Inc
1.98 794.76M 32.77M -440.22M -400.48M -1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.87 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
509.72 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
309.70 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.15 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
247.08 28.51B 3.81B -644.79M -669.77M -6.24

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-16 다운그레이드 UBS Buy → Neutral
2025-05-12 다운그레이드 Truist Buy → Hold
2025-05-09 다운그레이드 Citizens JMP Mkt Outperform → Mkt Perform
2024-10-24 개시 UBS Buy
2024-07-29 다운그레이드 Piper Sandler Overweight → Neutral
2023-11-20 개시 Goldman Buy
2023-09-18 재확인 Barclays Overweight
2023-05-30 업그레이드 Wells Fargo Equal Weight → Overweight
2023-03-27 재개 Wells Fargo Equal Weight
2023-01-27 업그레이드 Piper Sandler Neutral → Overweight
2022-12-09 다운그레이드 Goldman Buy → Neutral
2022-10-31 개시 Guggenheim Neutral
2022-08-18 재개 Wells Fargo Equal Weight
2022-01-28 업그레이드 Stifel Hold → Buy
2021-12-07 재개 Cowen Outperform
2021-06-10 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2021-05-20 다운그레이드 Piper Sandler Overweight → Neutral
2021-05-19 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2021-05-19 다운그레이드 Stifel Buy → Hold
2021-05-03 개시 Truist Buy
2021-04-16 개시 Goldman Buy
2021-03-08 업그레이드 H.C. Wainwright Neutral → Buy
2020-12-15 다운그레이드 H.C. Wainwright Buy → Neutral
2020-10-06 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-04-22 개시 Mizuho Buy
2020-03-04 개시 Barclays Overweight
2020-02-26 재확인 H.C. Wainwright Buy
2020-02-26 재확인 Oppenheimer Outperform
2019-12-18 개시 JMP Securities Mkt Outperform
2019-10-01 개시 Stifel Buy
2019-04-29 개시 Piper Jaffray Overweight
2019-02-28 재확인 Chardan Capital Markets Buy
2019-02-07 개시 Robert W. Baird Outperform
2018-12-31 재개 B. Riley FBR Buy
2018-07-06 재확인 Chardan Capital Markets Buy
2018-04-10 업그레이드 B. Riley FBR, Inc. Neutral → Buy
2018-03-13 재확인 B. Riley FBR, Inc. Neutral
2018-02-23 다운그레이드 B. Riley FBR, Inc. Buy → Neutral
2018-01-25 재확인 H.C. Wainwright Buy
2017-11-01 재확인 B. Riley FBR, Inc. Buy
모두보기

Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent

Jun 18, 2025
pulisher
Jun 18, 2025

The Gross Law Firm Notifies Shareholders of Iovance Biotherapeutics, Inc. (IOVA) of a Class ... - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - FinancialContent

Jun 18, 2025
pulisher
Jun 18, 2025

Wealth Enhancement Advisory Services LLC Lowers Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal PressureHagens Berman - ACCESS Newswire

Jun 18, 2025
pulisher
Jun 17, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK - Bluefield Daily Telegraph

Jun 17, 2025
pulisher
Jun 17, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

ROSEN, A LEADING LAW FIRM, Encourages Iovance - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph

Jun 17, 2025
pulisher
Jun 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky Before July 14, 2025 to Join Class Action - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class ActionIOVA - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025 – Contact Levi & Korsinsky - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance ... - Eagle-Tribune

Jun 15, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 15, 2025

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 14, 2025

Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline - ACCESS Newswire

Jun 14, 2025
pulisher
Jun 14, 2025

Iovance Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationIOVA - The Victoria Advocate

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance - GlobeNewswire

Jun 14, 2025
pulisher
Jun 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView

Jun 14, 2025
pulisher
Jun 14, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider

Jun 14, 2025
pulisher
Jun 14, 2025

Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating - Seeking Alpha

Jun 14, 2025
pulisher
Jun 14, 2025

IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA) - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

iovance cfo resigns to pursue new opportunities By Investing.com - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

iovance cfo resigns to pursue new opportunities - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance Biotherapeutics IncJean-Marc Bellemin To Resign As CFO - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance Biotherapeutics’ SWOT analysis: TIL therapy stock faces challenges amid promise - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

Jun 13, 2025
pulisher
Jun 13, 2025

Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 13, 2025
pulisher
Jun 13, 2025

Investors who lost money on Iovance Biotherapeutics, Inc. (IOVA) should contact Levi & ... - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

Investors who lost money on Iovance Biotherapeutics, Inc. - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

IOVA CLASS ACTION: Invest in Iovance Biotherapeutics, Inc.? - GlobeNewswire

Jun 13, 2025
pulisher
Jun 12, 2025

Levi & Korsinsky Urges Iovance Biotherapeutics, Inc. (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025 - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor LawsuitHagens Berman - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance Biotherapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross ... - Bluefield Daily Telegraph

Jun 12, 2025
pulisher
Jun 12, 2025

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Victoria Advocate

Jun 12, 2025
pulisher
Jun 12, 2025

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire

Jun 12, 2025

Iovance Biotherapeutics Inc (IOVA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Iovance Biotherapeutics Inc 주식 (IOVA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Puri Raj K.
Chief Regulatory Officer
Jun 02 '25
Option Exercise
0.00
5,469
0
212,321
Vogt Frederick G
Interim CEO & General Counsel
Jun 02 '25
Option Exercise
0.00
52,085
0
426,731
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
Jun 02 '25
Option Exercise
0.00
12,695
0
105,608
BILINSKY IGOR
Chief Operating Officer
Jun 02 '25
Option Exercise
0.00
12,305
0
99,883
Bellemin Jean-Marc
Chief Financial Officer
Jun 02 '25
Option Exercise
0.00
8,789
0
64,993
Puri Raj K.
Chief Regulatory Officer
May 23 '25
Buy
1.74
5,600
9,743
206,852
Vogt Frederick G
Interim CEO & General Counsel
May 14 '25
Buy
1.69
25,000
42,250
374,646
Puri Raj K.
Chief Regulatory Officer
Mar 14 '25
Option Exercise
0.00
8,334
0
203,761
Bellemin Jean-Marc
Chief Financial Officer
Mar 03 '25
Option Exercise
0.00
58,590
0
87,938
BILINSKY IGOR
Chief Operating Officer
Mar 03 '25
Option Exercise
0.00
62,106
0
120,880
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
자본화:     |  볼륨(24시간):